Session Information
2007 BIO International Convention
Click here to go to the previous page
Mining for Gold: Top Biotech Venture Capital Markets
Track : Emerging Company Issues
Program Code: ECI020
Date: Sunday, May 6, 2007
Time: 4:00 PM to 5:30 PM  
Location: 210 A
CHAIR :
Robert J. More, Partner, Domain Associates
SPEAKER (S):
Mark Heesen
Michael Lytton, General Partner, Oxford BioSciences Partners
Art Pappas, Managing Partner, Pappas Ventures
Camille Samuels, MBA, Managing Director
Description
Regional leaders from across the United States are fighting hard to lure what many believe is the economic growth industry of the 21st century— biotechnology, and most economists say access to venture capital funding is a critical element to build the kind of cluster that can be found in San Diego, San Francisco and Boston. Hear from this all-star panel of venture capitalists from biotech's top markets on why they have chosen to settle in their respective regions.



Objectives:
  • Hear directly from VCs what is most important to them when considering their next investment.

  • Discover the crucial factors to VCs when shaping their economic winners and losers.

  • Understand the most important demographic elements when deciding where to base your biotech company.


  • Streaming Audio with
    PowerPoint Slides
    (Code: ECI020)
      
    This session is a part of: